The short version
13 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Carbidopa and Levodopa
Carbidopa and Levodopa · CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 · Tablet, Extended Release · Oral · Alembic Pharmaceuticals Inc.
NDC 62332-0332-30 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for carbidopa and levodopa (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA210341
- TE code
- AB
- Approval date
- Jun 5, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Carbidopa and Levodopa (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Accord Healthcare, Inc. | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Accord Healthcare, Inc. | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals NY LLC | CARBIDOPA HYDRATE 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals NY LLC | CARBIDOPA HYDRATE 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional Inc. | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional Inc. | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NCS HealthCare of KY, LLC dba Vangard Labs | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NCS HealthCare of KY, LLC dba Vangard Labs | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Radha Pharmaceuticals Inc | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Radha Pharmaceuticals Inc | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Safecor Health, LLC | CARBIDOPA HYDRATE 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Safecor Health, LLC | CARBIDOPA HYDRATE 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ScieGen Pharmaceuticals Inc | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ScieGen Pharmaceuticals Inc | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | CARBIDOPA 25 mg/1; LEVODOPA 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | CARBIDOPA 50 mg/1; LEVODOPA 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Carbidopa and Levodopa — NDC 62332-0332-30," retrieved September 3, 2026, https://drugdashboards.com/drug/62332033230.
Free to cite with attribution — see how the data is put together.